Showing results (21-30 of 166) with videos related to
Sort By:
Pageof 17
Molecular Pharmacology|May 1, 1994
5-Hydroxytryptamine type 2A and 2C receptors linked to Na+/K+/Cl- cotransportS E Mayer, E Sanders-BushMolecular Pharmacology|October 1, 1993
5-hydroxytryptamine1C receptor density and mRNA levels in choroid plexus epithelial cells after treatment with mianserin and (-)-1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropaneE L Barker, E Sanders-BushTrends in Pharmacological Sciences|October 1, 1991
From neurotransmitter to gene: identifying the missing linksT M Esterle, E Sanders-BushJournal of Neurochemistry|October 1, 1994
Regulation of serotonin2A receptors in heterologous expression systemsM S Grotewiel, E Sanders-BushNaunyn-Schmiedeberg'S Archives of Pharmacology|December 1, 1982
Comparison of the pharmacological characteristics of 5 HT1 and 5 HT2 binding sites with those of serotonin autoreceptors which modulate serotonin releaseL L Martin, E Sanders-BushMolecular Pharmacology|November 1, 1992
Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamideK D Burris, E Sanders-BushThe Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 1, 1992
Serotonin agonists increase transferrin levels via activation of 5-HT1C receptors in choroid plexus epitheliumT M Esterle, E Sanders-BushJournal of Neuroscience Methods|December 24, 1997
Generation of anti-peptide antibodies against serotonin 5-HT2A and 5-HT2C receptorsJ R Backstrom, E Sanders-BushEuropean Journal of Pharmacology|August 8, 1980
Long-term effects of continuous exposure to amphetamine on brain dopamine concentration and synaptosomal uptake in miceL R Steranka, E Sanders-BushNaunyn-Schmiedeberg'S Archives of Pharmacology|February 5, 1999
Differences in agonist-independent activity of 5-Ht2A and 5-HT2c receptors revealed by heterologous expressionM S Grotewiel, E Sanders-BushPageof 17